Dear Sir/Madam, Please find the attached Annual Report for the financial year ended 31st March, 2025. Thanking You.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Prism Medico and Pharmacy Ltd has filed its Annual Report for the financial year ended March 31, 2025 with BSE and MSEI, as required under Regulation 34 of SEBI's Listing Regulations. Revenue from operations fell sharply to Rs. 63.19 lakhs from Rs. 292.52 lakhs in FY24, a drop of about 78%. The company reported a net loss of Rs. 4.87 lakhs for FY25, wider than the Rs. 2.14 lakh loss in the previous year, and the Board has not recommended any dividend. During the year, statutory auditor M/s. Harjeet Parvesh & Co resigned (effective July 16, 2025) and was replaced by M/s. Garg Mendiratta & Associates. The 23rd Annual General Meeting is scheduled for September 30, 2025 via video conferencing, where shareholders will vote on the auditor's appointment and approval of related party transactions of up to Rs. 60 crores.
The steep revenue decline and continued losses point to ongoing operational weakness, which is a negative signal for shareholders. The mid-year auditor change and absence of any dividend may also dent investor confidence in the near term.